AR057137A1 - Compuestos orgánicos - Google Patents
Compuestos orgánicosInfo
- Publication number
- AR057137A1 AR057137A1 ARP060104197A ARP060104197A AR057137A1 AR 057137 A1 AR057137 A1 AR 057137A1 AR P060104197 A ARP060104197 A AR P060104197A AR P060104197 A ARP060104197 A AR P060104197A AR 057137 A1 AR057137 A1 AR 057137A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- alkyl
- hydrogen
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Abstract
La invencion se refiere a un proceso novedoso, a pasos de proceso novedosos, y a intermediarios novedosos utiles en la síntesis de compuestos farmacéuticamente activos, en especial inhibidores de renina, tales como alisquireno. REIVINDICACIoN 1.- Un proceso para la fabricacion de un compuesto de la Formula (3) en donde: R es hidrogeno, alquilo, o alcoxi-alquilo; R1 es hidrogeno, alquilo, o alcoxi-alquilo; y R' es hidrogeno, alquilo, o aralquilo; o una sal del mismo; comprendiendo esta fabricacion (de preferencia consistiendo en): hacer reaccionar un compuesto de la Formula (1) en donde R y R1 son como se definen para un compuesto de la Formula (3), con un compuesto de glicina de la Formula (2): en donde R' es como se define para un compuesto de la Formula (3), con el objeto de dar la funcionalidad de imina. Entre otras cosas, la invencion se refiere a un proceso para la fabricacion de un compuesto de la Formula (3) en donde R, R1 y R' son como se definen en la memoria descriptiva, o una sal del mismo, y un compuesto de la Formula (4): en donde R, R1, R2, y R' son como se definen en la memoria descriptiva, y a procesos para la fabricacion de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0519764.5A GB0519764D0 (en) | 2005-09-28 | 2005-09-28 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057137A1 true AR057137A1 (es) | 2007-11-21 |
Family
ID=35394904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060104197A AR057137A1 (es) | 2005-09-28 | 2006-09-26 | Compuestos orgánicos |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US7973175B2 (es) |
| EP (2) | EP2287153A1 (es) |
| JP (1) | JP2009509990A (es) |
| KR (1) | KR20080048042A (es) |
| CN (1) | CN101273012A (es) |
| AR (1) | AR057137A1 (es) |
| AT (1) | ATE492533T1 (es) |
| AU (1) | AU2006299097B2 (es) |
| BR (1) | BRPI0616707A2 (es) |
| CA (1) | CA2623495A1 (es) |
| DE (1) | DE602006019114D1 (es) |
| EC (1) | ECSP088319A (es) |
| ES (1) | ES2358536T3 (es) |
| GB (1) | GB0519764D0 (es) |
| GT (1) | GT200600427A (es) |
| IL (1) | IL189763A0 (es) |
| MA (1) | MA29852B1 (es) |
| MY (1) | MY143251A (es) |
| NO (1) | NO20082005L (es) |
| NZ (1) | NZ566429A (es) |
| PE (1) | PE20070488A1 (es) |
| PL (1) | PL1931629T3 (es) |
| PT (1) | PT1931629E (es) |
| RU (1) | RU2423348C2 (es) |
| TN (1) | TNSN08142A1 (es) |
| TW (1) | TW200730480A (es) |
| WO (1) | WO2007039183A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2062874B1 (en) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Process and intermediates for the preparation of aliskiren |
| SI2189442T1 (sl) | 2008-11-20 | 2015-03-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek in intermediati za pripravo aliskirena |
| US8203005B2 (en) | 2009-10-29 | 2012-06-19 | Carbo Design Llc | Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren |
| CN101863796B (zh) * | 2010-05-12 | 2011-08-24 | 海南美兰史克制药有限公司 | 一种阿利克仑化合物及其制法 |
| EP2551260A1 (en) | 2011-07-28 | 2013-01-30 | Chemo Ibérica, S.A. | Chemical process for opening ring compounds |
| US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3421295A1 (de) | 1984-06-08 | 1985-12-12 | Basf Ag, 6700 Ludwigshafen | Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung |
| MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| NZ523088A (en) | 2000-07-05 | 2004-06-25 | Speedel Pharma Ag | Process for the preparation of substituted octanoyl amides, the compounds and intermediates thereof |
| DE10116816A1 (de) * | 2001-04-04 | 2002-10-17 | Basf Ag | Verfahren zur Herstellung von N-Benzylaminen |
| GB0419361D0 (en) | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
-
2005
- 2005-09-28 GB GBGB0519764.5A patent/GB0519764D0/en not_active Ceased
-
2006
- 2006-09-25 GT GT200600427A patent/GT200600427A/es unknown
- 2006-09-26 DE DE602006019114T patent/DE602006019114D1/de active Active
- 2006-09-26 RU RU2008116317/04A patent/RU2423348C2/ru not_active IP Right Cessation
- 2006-09-26 PL PL06805861T patent/PL1931629T3/pl unknown
- 2006-09-26 JP JP2008532650A patent/JP2009509990A/ja active Pending
- 2006-09-26 AU AU2006299097A patent/AU2006299097B2/en not_active Ceased
- 2006-09-26 BR BRPI0616707-1A patent/BRPI0616707A2/pt not_active IP Right Cessation
- 2006-09-26 KR KR1020087007396A patent/KR20080048042A/ko not_active Application Discontinuation
- 2006-09-26 WO PCT/EP2006/009323 patent/WO2007039183A1/en active Application Filing
- 2006-09-26 AT AT06805861T patent/ATE492533T1/de active
- 2006-09-26 AR ARP060104197A patent/AR057137A1/es not_active Application Discontinuation
- 2006-09-26 US US12/067,055 patent/US7973175B2/en not_active Expired - Fee Related
- 2006-09-26 CN CNA2006800353469A patent/CN101273012A/zh active Pending
- 2006-09-26 NZ NZ566429A patent/NZ566429A/en not_active IP Right Cessation
- 2006-09-26 EP EP10178025A patent/EP2287153A1/en not_active Withdrawn
- 2006-09-26 PE PE2006001166A patent/PE20070488A1/es not_active Application Discontinuation
- 2006-09-26 CA CA002623495A patent/CA2623495A1/en not_active Abandoned
- 2006-09-26 MY MYPI20080623A patent/MY143251A/en unknown
- 2006-09-26 PT PT06805861T patent/PT1931629E/pt unknown
- 2006-09-26 EP EP06805861A patent/EP1931629B1/en not_active Not-in-force
- 2006-09-26 ES ES06805861T patent/ES2358536T3/es active Active
- 2006-09-27 TW TW095135800A patent/TW200730480A/zh unknown
-
2008
- 2008-02-25 IL IL189763A patent/IL189763A0/en unknown
- 2008-03-27 EC EC2008008319A patent/ECSP088319A/es unknown
- 2008-03-27 TN TNP2008000142A patent/TNSN08142A1/en unknown
- 2008-04-04 MA MA30815A patent/MA29852B1/fr unknown
- 2008-04-28 NO NO20082005A patent/NO20082005L/no not_active Application Discontinuation
-
2011
- 2011-05-26 US US13/116,349 patent/US20110230665A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20082005L (no) | 2008-06-24 |
| EP2287153A1 (en) | 2011-02-23 |
| RU2008116317A (ru) | 2009-11-10 |
| ECSP088319A (es) | 2008-04-28 |
| ES2358536T3 (es) | 2011-05-11 |
| US20110230665A1 (en) | 2011-09-22 |
| US20080255369A1 (en) | 2008-10-16 |
| TW200730480A (en) | 2007-08-16 |
| WO2007039183A1 (en) | 2007-04-12 |
| GT200600427A (es) | 2007-04-30 |
| US7973175B2 (en) | 2011-07-05 |
| MY143251A (en) | 2011-04-15 |
| GB0519764D0 (en) | 2005-11-09 |
| IL189763A0 (en) | 2008-08-07 |
| PT1931629E (pt) | 2011-03-09 |
| AU2006299097A1 (en) | 2007-04-12 |
| AU2006299097B2 (en) | 2010-11-04 |
| KR20080048042A (ko) | 2008-05-30 |
| CN101273012A (zh) | 2008-09-24 |
| PL1931629T3 (pl) | 2011-05-31 |
| PE20070488A1 (es) | 2007-06-13 |
| DE602006019114D1 (de) | 2011-02-03 |
| MA29852B1 (fr) | 2008-10-03 |
| RU2423348C2 (ru) | 2011-07-10 |
| JP2009509990A (ja) | 2009-03-12 |
| BRPI0616707A2 (pt) | 2011-06-28 |
| ATE492533T1 (de) | 2011-01-15 |
| TNSN08142A1 (en) | 2009-07-14 |
| EP1931629A1 (en) | 2008-06-18 |
| CA2623495A1 (en) | 2007-04-12 |
| NZ566429A (en) | 2010-10-29 |
| EP1931629B1 (en) | 2010-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088368A (es) | Derivados de 3-alquil-5-(4-alquil-5-oxo-tetrahidrofuran-2-il)-pirrolidin-2-ona como intermediarios en la síntesis de inhibidores de renina | |
| ECSP099708A (es) | Nuevos métodos | |
| ECSP077986A (es) | Procedimiento para preparar inhibidores de renina | |
| AR057137A1 (es) | Compuestos orgánicos | |
| PE20070805A1 (es) | Imidazopirazinas como inhibidores de proteinquinasa | |
| CO6450621A2 (es) | Sulfonamidas nematocidas | |
| AR054818A1 (es) | Proceso para preparar rosuvastatina e intermediarios | |
| ECSP078060A (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
| MX340572B (es) | Proceso para la fabricacion de compuestos farmaceuticamente activos. | |
| ECSP099818A (es) | Procesos para la preparacion de pirazoles | |
| PA8678901A1 (es) | Derivados de quinolina como agentes antibacteriales | |
| GT200500296A (es) | Sintesis asimetrica de derivados del dehidrobenzofurano | |
| ECSP066733A (es) | Polimorfos cristalinos de un ligando receptor de cxc-quimiocina | |
| MX2009013212A (es) | Proceso para la sintesis de intermediarios de los inhibidores de renina tales como alisquireno. | |
| IL190551A0 (en) | Novel process for the preparation of acid chlorides | |
| DOP2011000113A (es) | Pirazolilaminopiridinas como inhibidores de fak | |
| AR099594A2 (es) | Proceso para preparar bisulfato de atazanavir y otras formas | |
| AR049668A1 (es) | Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester. | |
| TW200726752A (en) | Process for the production of intermediates for the preparation of tricyclic benzimidazoles | |
| GT200400232A (es) | Metodos y composiciones para la inhibicion de selectina | |
| GT200600485A (es) | Proceso para la produccion de bifenilos | |
| ECSP099077A (es) | Formas polimórficas y proceso | |
| AR042946A1 (es) | Procedimiento para la fabricacion de alcaloides quinazolina | |
| MY141657A (en) | Novel intermediate for the preparation of therapeutically active imidazopyridines | |
| AR054663A1 (es) | Proceso de preparacion de carbamatos substituidos, compuestos intermedios para la sintesis de los mismos, forma cristalina del compuesto y composicion farmaceutica que lo contiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |